285 related articles for article (PubMed ID: 24434214)
1. Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity.
Li J; Xu Y; Long XD; Wang W; Jiao HK; Mei Z; Yin QQ; Ma LN; Zhou AW; Wang LS; Yao M; Xia Q; Chen GQ
Cancer Cell; 2014 Jan; 25(1):118-31. PubMed ID: 24434214
[TBL] [Abstract][Full Text] [Related]
2. Polycomb chromobox 4 enhances migration and pulmonary metastasis of hepatocellular carcinoma cell line MHCC97L.
Mei Z; Jiao H; Wang W; Li J; Chen G; Xu Y
Sci China Life Sci; 2014 Jun; 57(6):610-7. PubMed ID: 24838576
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of hypoxia inducible factor-1α and its significance in cancer.
Li J; Xu Y; Jiao H; Wang W; Mei Z; Chen G
Sci China Life Sci; 2014 Jul; 57(7):657-64. PubMed ID: 24916276
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
Han X; Wang XL; Li Q; Dong XX; Zhang JS; Yan QC
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1279-90. PubMed ID: 25877955
[TBL] [Abstract][Full Text] [Related]
5. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
[TBL] [Abstract][Full Text] [Related]
6. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma.
Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S
J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.
Huang GW; Yang LY; Lu WQ
World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555
[TBL] [Abstract][Full Text] [Related]
9. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Liu LP; Ho RL; Chen GG; Lai PB
Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
[TBL] [Abstract][Full Text] [Related]
11. CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma.
Wang X; Li L; Wu Y; Zhang R; Zhang M; Liao D; Wang G; Qin G; Xu RH; Kang T
Cancer Res; 2016 Dec; 76(24):7277-7289. PubMed ID: 27864346
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
13. Cbx4 governs HIF-1α to involve in Th9 cell differentiation promoting asthma by its SUMO E3 ligase activity.
Huang W; Yu C; Wu H; Liang S; Kang J; Zhou Z; Liu A; Liu L
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119524. PubMed ID: 37348765
[TBL] [Abstract][Full Text] [Related]
14. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
16. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
[TBL] [Abstract][Full Text] [Related]
18. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression.
Lee TK; Poon RT; Yuen AP; Man K; Yang ZF; Guan XY; Fan ST
Clin Cancer Res; 2006 Sep; 12(17):5082-9. PubMed ID: 16951224
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma.
Jiao HK; Xu Y; Li J; Wang W; Mei Z; Long XD; Chen GQ
Cell Death Dis; 2015 Mar; 6(3):e1689. PubMed ID: 25766328
[TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]